VIM-2–producing Pseudomonas putida, Buenos Aires

نویسندگان

  • Marisa Almuzara
  • Marcela Radice
  • Natalia de Gárate
  • Alejandra Kossman
  • Arabela Cuirolo
  • Gisela Santella
  • Angela Famiglietti
  • Gabriel Gutkind
  • Varolos Vay
چکیده

To the Editor: Pseudomonas putida infections (0.03% of isolates from the culture collection of inpa-tients, SIR Program 2003–2004, www.aam.org.ar) are mainly reported in immunocompromised patients, such as newborns, neutropenic patients, and cancer patients. They are usually susceptible to extended-spectrum cephalosporins, aminoglyco-sides, fluoroquinolones, and car-bapenems. However, isolates have been identified that produce acquired metallo-β-lactamases (MBLs) and are resistant to most β-lactams, including carbapenems. Two multidrug-resistant P. puti-da isolates were obtained from clinical samples at the Sanatorio Mater Dei in Buenos Aires. One isolate was obtained in March 2005 from a urine specimen of a 76-year-old woman with a urinary tract infection who was using a urethral catheter. The second isolate was obtained in May 2005 from a tracheal aspirate of a 67-year-old man with nosocomial pneumonia. Bacteria were identified by using conventional biochemical tests and the API 20NE System (API, bioMérieux, Lyon, France). Susceptibility tests were performed according to standard procedures. Both isolates were resistant to imi-penem and meropenem (MICs >32 µg/mL) but were susceptible to amikacin and colistin. Susceptibility data are shown in the Table. Screening for MBLs was performed by using a double-disk diffusion method. Disks containing 1 µmol EDTA (metal chelator) were placed on Mueller-Hinton agar plates containing the 2 isolates. Disks containing carbapenem were placed 15 mm from disks containing EDTA. An increase in the inhibition zone of the disk containing drug near the disk containing EDTA was observed for both isolates, which suggested the presence of MBLs. PCR amplification of imp and vim genes was conducted by using primers based on conserved regions of the imp and vim genes (blaIMP-F: 5′-GAAG-G C G T T TAT G T T C ATA C T T-3 ′ , blaIMP-R: 5′-GTTTGCCTTACCAT ATTTGGA-3′, blaVIMG-F: 5′-GGT-GTTTGGTCGCATATC-3′, and bla VIMG-R 5′-TGGGCCATTCAGC CAGATC-3′) and heat-extracted DNA as template. Reactions were performed in a T-gradient instrument (Biometra, Göttingen, Germany) with the following reaction conditions: 1 cycle at 95°C for 5 min, 52°C for 15 min, and 72°C for 6 min, followed by 30 cycles at 95°C for 1 min, 52°C for 1 min, and 72°C for 1 min, and a final reaction at 72°C for 20 min. Amplified fragments were sequenced on both strands by using an ABI Prism DNA 3700 (Applied Biosystems, Foster City, CA, USA), and nucleotide sequences were compared by using BLAST Tools/). Nucleotide sequences were completely homologous to the vim-2 coding gene. were used to characterize isolates. PCR conditions were …

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme.

A total of 209 clinical isolates of Pseudomonas (193 Pseudomonas aeruginosa, 10 P. putida, 4 P. stutzeri, and 2 P. fluorescens isolates) with reduced susceptibilities to imipenem and/or ceftazidime were subjected to PCR assays with primers specific for bla(IMP-1), bla(IMP-2), bla(VIM-1), and bla(VIM-2) and sequence analysis to identify the metallo-beta-lactamases (MBLs) prevalent among these or...

متن کامل

Title : Isolation of VIM - 2 - producing Pseudomonas monteilii clinical strains Disseminated 1 in a Tertiary Hospital in Northern Spain

23 We describe the occurrence of blaVIM-2 in 10 carbapenem-resistant Pseudomonas monteilii 24 strains isolated from different clinical samples in our hospital in Northern Spain. All the 25 blaVIM-2-harbouring P. monteilii isolates possessed a class 1 integron, with the cassette array 26 [intI1_blaVIM-2_aac(6’)-Ib_qacE1_sul1]. Our results show the emergence of VIM-227 producing multidrug-resist...

متن کامل

Multidrug-resistant Acinetobacter baumannii, Russia

Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 4, April 2007 669 levels of susceptibility because the MIC50 was only 1 dilution below the current breakpoint (7,8). Aztreonam resistance could not be transferred by conjugation between IMP-1–producing (aztreonam-resistant) P. putida and P. aeruginosa (2) and is not associated with a transposon carrying blaVIM-2 (6). No evidence of e...

متن کامل

Title: Isolation of VIM-2-producing Pseudomonas monteilii clinical strains Disseminated

23 We describe the occurrence of blaVIM-2 in 10 carbapenem-resistant Pseudomonas monteilii 24 strains isolated from different clinical samples in our hospital in Northern Spain. All the 25 blaVIM-2-harbouring P. monteilii isolates possessed a class 1 integron, with the cassette array 26 [intI1_blaVIM-2_aac(6’)-Ib_qacE1_sul1]. Our results show the emergence of VIM-227 producing multidrug-resist...

متن کامل

Anti-Trypanosoma cruzi activity of extracts from Argentinean Asteraceae species

The anti-Trypanosoma cruzi activity of extracts from 13 Argentinean Asteraceae species was determined. Dichloromethane and methanol extracts of Acmella bellidioides, Aspilia silphioides, Viguiera tuberosa, Calyptocarpus biaristatus, Hyalis argentea, Helenium radiatum, Gaillardia megapotamica, Verbesina subcordata, Gymnocoronis spilanthoides, Viguiera anchusaefolia, Thelesperma megapotamicum, Ze...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 13  شماره 

صفحات  -

تاریخ انتشار 2007